Human prostate fibroblasts induce growth and confer castration resistance and metastatic potential in LNCaP Cells
- PMID: 19747763
- PMCID: PMC2889152
- DOI: 10.1016/j.eururo.2009.08.026
Human prostate fibroblasts induce growth and confer castration resistance and metastatic potential in LNCaP Cells
Abstract
Background: The tumor microenvironment is important for progressive and metastatic disease.
Objective: To study the hypothesis that prostate fibroblasts have differential ability to induce castration-resistant prostate cancer (PCa) and metastatic progression and whether this effect might vary depending on the zonal origin of the fibroblast.
Design, setting, and participants: Human prostate fibroblasts from the peripheral (PZ), transition (TZ) and central (CZ) zones of radical prostatectomy specimens (n=13) were isolated and compared for their ability to promote androgen independence and metastatic progression in androgen-responsive PCa lymph node carcinoma of the prostate (LNCaP) cells in vivo.
Interventions: By coinoculating marginally tumorigenic LNCaP cells with PZ or TZ and by altering host hormonal milieu, a series of tumorigenic and metastatic LNCaP epithelial sublines-P4, P4-2 (derivatives from interaction with PZ), T4, and T4-2 (derivatives from interaction with TZ)-were established and characterized.
Measurements: In vivo and in vitro evaluation of induction of tumor growth and metastatic potential.
Results and limitations: 1) LNCaP sublines were permanently altered in their cytogenetic and biologic profiles after cellular interaction with prostate stromal fibroblasts. LNCaP sublines grew faster under anchorage-dependent and -independent conditions, expressed 1-12-fold more prostate-specific antigen in vitro than LNCaP cells, and gained metastatic potential; 2) zonal differences of stromal fibroblasts in their ability to induce the growth and progression of LNCaP tumors as xenografts in mice may exist but need further analysis; 3) PZ-conditioned medium induced more anchorage-independent growth of LNCaP cells in vitro. TZ had a higher growth rate and were more sensitive to dihydrotestosterone.
Conclusions: We demonstrate that prostate fibroblasts have growth inductive potential on PCa cells and affect their subsequent progression to castration resistance and development of a metastatic phenotype.
Copyright 2009 European Association of Urology. All rights reserved.
Figures















Comment in
-
Editorial comment on: human prostate fibroblasts induce growth and confer castration resistance and metastatic potential in LNCaP cells.Eur Urol. 2010 Jul;58(1):171-2. doi: 10.1016/j.eururo.2009.08.027. Epub 2009 Sep 4. Eur Urol. 2010. PMID: 19747764 No abstract available.
References
-
- Jemal A, Murray T, Samuels A, et al. Cancer statistics. CA Cancer J Clin. 2003;53:5–26. - PubMed
-
- Gleave ME, Hsieh JT, von Eschenbach AC, Chung LW. Prostate and bone fibroblasts induce human prostate cancer growth in vivo: implications for bidirectional tumor-stromal cell interaction in prostate carcinoma growth and metastasis. J Urol. 1992;147:1151–9. - PubMed
-
- Thalmann GN, Anezinis PE, Chang SM, et al. Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. Cancer Res. 1994;54:2577–81. - PubMed
-
- Thalmann GN, Sikes RA, Wu TT, et al. LNCaP progression model of human prostate cancer: androgen-independence and osseous metastasis. Prostate. 2000;44:91–103. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 CA082739/CA/NCI NIH HHS/United States
- CA 119338/CA/NCI NIH HHS/United States
- R01 CA108468/CA/NCI NIH HHS/United States
- P20 CA132388/CA/NCI NIH HHS/United States
- P01 CA098912/CA/NCI NIH HHS/United States
- CA 108468/CA/NCI NIH HHS/United States
- CA 082739/CA/NCI NIH HHS/United States
- CA63863/CA/NCI NIH HHS/United States
- CA 132388/CA/NCI NIH HHS/United States
- CA 098912/CA/NCI NIH HHS/United States
- R01 CA122602/CA/NCI NIH HHS/United States
- U54 CA119338/CA/NCI NIH HHS/United States
- CA63341/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical